A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age

Le Saux, Nicole; Gaboury, Isabelle; Baird, Marian; Klassen, Terry P.; MacCormick, Johnna; Blanchard, Colline; Pitters, Carrol; Sampson, Margaret; Moher, David
February 2005
CMAJ: Canadian Medical Association Journal;2/1/2005, Vol. 172 Issue 3, p335
Academic Journal
Objectives: Debate continues with respect to a "watch and wait" approach versus immediate antibiotic treatment for the initial treatment of acute otitis media. In this double-blind noninferiority trial, we compared clinical improvement rates at 14 days for children (6 months to 5 years of age) with acute otitis media who were randomly assigned to receive amoxicillin or placebo. Methods: We enrolled healthy children who presented to clinics or the emergency department with a new episode of acute otitis media during the fall and winter months in Ottawa (from December 1999 to the end of March 2002). The children were randomly assigned to receive amoxicillin (60 mg/kg daily) or placebo for 10 days. Telephone follow-up was performed on each of days 1, 2 and 3 and once between day 10 and day 14. The primary outcome was clinical resolution of symptoms, defined as absence of receipt of an antimicrobial (other than the amoxicillin in the treatment group) at any time during the 14-day period. Secondary outcomes were the presence of pain and fever and the activity level in the first 3 days, recurrence rates, and the presence of middle ear effusion at 1 and 3 months. Results: According to clinical scoring, 415 of the 512 children who could be evaluated had moderate disease. At 14 days 84.2% of the children receiving placebo and 92.8% of those receiving amoxicillin had clinical resolution of symptoms (absolute difference -8.6%, 95% confidence interval -14.4% to -3.0%). Children who received placebo had more pain and fever in the first 2 days. There were no statistical differences in adverse events between the 2 groups, nor were there any significant differences in recurrence rates or middle ear effusion at 1 and 3 months. Interpretation: Our results did not support the hypothesis that placebo was noninferior to amoxicillin (i.e., that the 14-day cure rates among children with clinically diagnosed acute otitis media would not be substantially worse in the placebo group than ...


Related Articles

  • Antibiotics for Acute Otitis Media in Young Children. DARBY-STEWART, ANDREA; GRABER, MARK A.; DACHS, ROBERT // American Family Physician;11/15/2011, Vol. 84 Issue 10, p1095 

    The article examines whether antibiotics should be used for the treatment of acute otitis media (AOM) in young children. It reveals the outcome of two studies on young children with a certain diagnosis of AOM who were randomized to either amoxicillin/clavulanate (Augmentin) or placebo. It cites...

  • Efficacy of Antibiotics for Acute Otitis Media. Walling, Anne D. // American Family Physician;8/15/2000, Vol. 62 Issue 4, p869 

    Presents information on a study by R.A. Damoiseaux and others that compared the efficacy of amoxicillin with that of placebo in the treatment of acute otitis media in children younger than two years. Description of the study and its results; Conclusion that early symptom resolution was more...

  • Managing OME in an otherwise healthy younger child.  // Patient Care for the Nurse Practitioner;Apr2002, Vol. 5 Issue 4, p1 

    The article discusses otitis media with effusion (OME) in children. OME is the fluid in the middle ear without signs or symptoms of infection. It applies only to a child aged 1 through 3 years old with no craniofacial or neurologic abnormalities or sensory deficits and is healthy except for OME....

  • Handling the scourge of pediatric ear infections.  // Medical Update;Sep99, Vol. 23 Issue 3, p3 

    Details findings of a study by the University of Manitoba in Winnipeg which showed that children suffering from otitis media (OM), the infection of the middle, maybe treated with a five-day course of antibiotics and a nasal vaccine spray, called FluMist.

  • Good news about ear infections. Harding, Anne // Baby Talk;Apr2003, Vol. 68 Issue 3, p15 

    Provides information on acute otitis media or middle ear infection in children. Symptoms; Diagnosis; Treatment.

  • Gatifloxacin Therapy for Children: An Antibiotic Still in the "Back Room". Marchant, Colin D. // Clinical Infectious Diseases;8/15/2005, Vol. 41 Issue 4, p479 

    The article focuses on gatifloxacin therapy for children with acute otitis media. Gatifloxacin eliminates middle-ear pathogens at rates comparable or superior to those achieved by other antibacterial agents, and as a result, high clinical response rates are achieved. Clinical trials comparing...

  • Literature Reviews: Pediatric Infectious Diseases. Steele, Russell W.; Lampe, John B. // Clinical Pediatrics;Dec1998, Vol. 37 Issue 12, p757 

    Comments on and discusses the abstract of the article `Amoxicillin Middle Ear Fluid Penetration and Pharmacokinetics in Children with Acute Otitis Media,' by D.M. Cinafax, Z. Yuan and T. Chonmaitree et al taken from the 1998 issue of `Pediatric Infectious Disease Journal'. Amoxicillin as...

  • Antibiotics of dubious value in childhood ear infections.  // Foods Matter (USA);Apr2008, p17 

    The article reports on the result of a study conducted by the University Medical Center in Utrecht, Netherlands which reveals that antibiotics prescribed for otitis media do not prevent the build up of fluid in the middle ear which often leads on to the development of much more serious acute...

  • Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants. Bezáková, Natália; Damoiseaux, Roger A. M. J.; Hoes, Arno W.; Schilder, Anne G. M.; Rovers, Maroeska M. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/11/2009, Vol. 339 Issue 7712, p96 

    Objective To determine the long term effects of antibiotic treatment for acute otitis media in young children. Design Prospective three year follow-up study within the framework of a primary care based, double blind, randomised, placebo controlled trial. Setting 53 general practices in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics